bioAffinity Technologies, Inc. Interest Expense Nonoperating
bioAffinity Technologies, Inc. (BIAF) reported Interest Expense Nonoperating of $11.69 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-07
- bioAffinity Technologies, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $11.69K, a 11.74% increase year-over-year.
- bioAffinity Technologies, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $14.72K, a 4.93% decline year-over-year.
- bioAffinity Technologies, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $13.07K, a 47.82% decline year-over-year.
- bioAffinity Technologies, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $5.36K, a 75.23% decline year-over-year.
- bioAffinity Technologies, Inc. interest expense nonoperating for fiscal 2025 was $44.37K, a 52.02% decline from fiscal 2024.
- bioAffinity Technologies, Inc. interest expense nonoperating for fiscal 2024 was $92.47K, a 149.09% increase from fiscal 2023.
- bioAffinity Technologies, Inc. interest expense nonoperating for fiscal 2023 was $37.13K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.69K 10-Q · filed 2026-08-07 | $26.41K 10-Q · filed 2026-08-07 | $39.48K derived: sum of 3 quarters · filed 2026-08-07 | $44.84K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $14.72K 10-Q · filed 2026-05-11 | $27.79K derived: sum of 2 quarters · filed 2026-05-11 | $33.15K derived: sum of 3 quarters · filed 2026-05-11 | $43.61K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $13.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $18.43K derived: sum of 2 quarters · filed 2026-03-16 | $28.89K derived: sum of 3 quarters · filed 2026-08-07 | $44.37K 10-K · filed 2026-03-16 |
| 2025-09-30 | $5.36K 10-Q · filed 2025-11-14 | $15.82K derived: sum of 2 quarters · filed 2026-08-07 | $31.30K 10-Q · filed 2025-11-14 | $56.35K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $10.46K 10-Q · filed 2026-08-07 | $25.95K 10-Q · filed 2026-08-07 | $50.99K derived: sum of 3 quarters · filed 2026-08-07 | $72.62K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $15.48K 10-Q · filed 2026-05-11 | $40.53K derived: sum of 2 quarters · filed 2026-05-11 | $62.16K derived: sum of 3 quarters · filed 2026-05-11 | $84.41K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $25.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $46.68K derived: sum of 2 quarters · filed 2026-03-16 | $68.92K derived: sum of 3 quarters · filed 2026-03-16 | $92.47K 10-K · filed 2026-03-16 |
| 2024-09-30 | $21.63K 10-Q · filed 2025-11-14 | $43.88K derived: sum of 2 quarters · filed 2025-11-14 | $67.43K 10-Q · filed 2025-11-14 | $92.75K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $22.25K 10-Q · filed 2025-08-14 | $45.80K 10-Q · filed 2025-08-14 | $71.12K derived: sum of 3 quarters · filed 2025-08-14 | $79.91K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $23.55K 10-Q · filed 2025-05-15 | $48.87K derived: sum of 2 quarters · filed 2025-05-15 | $57.66K derived: sum of 3 quarters · filed 2025-05-15 | $59.02K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $25.32K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $34.11K derived: sum of 2 quarters · filed 2025-03-31 | $35.47K derived: sum of 3 quarters · filed 2025-03-31 | $37.13K 10-K · filed 2025-03-31 |
| 2023-09-30 | $8.79K 10-Q · filed 2024-11-14 | $10.14K derived: sum of 2 quarters · filed 2024-11-14 | $11.80K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $1.36K 10-Q · filed 2024-08-14 | $3.02K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |